Technical Analysis for UTRS - Minerva Surgical, Inc.

Grade Last Price % Change Price Change
D 5.59 1.45% 0.08
UTRS closed up 1.45 percent on Tuesday, December 7, 2021, on 1.5 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong N/A N/A Down
Historical UTRS trend table...

Date Alert Name Type % Chg
Pocket Pivot Bullish Swing Setup 0.00%
NR7 Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish 1.45%
Inside Day Range Contraction 1.45%
Wide Bands Range Expansion 1.45%
Oversold Stochastic Weakness 1.45%
Hot IPO Pullback Bullish Swing Setup -4.61%
Doji - Bullish? Reversal -4.61%
Older End-of-Day Signals for UTRS ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Rose Above Previous Day's High about 11 hours ago
10 DMA Resistance about 11 hours ago
Outside Day about 11 hours ago
Down 5% about 11 hours ago
Down 3% about 11 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Minerva Surgical, Inc. Description

Minerva Surgical Inc., a commercial-stage medical technology company, focuses on developing, manufacturing, and commercializing minimally invasive solutions to meet the uterine healthcare needs of women. The company offers Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists across various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.


Sector: Healthcare
Industry: Health Information Services
Keywords: Medicine Medical Technology Anatomy Ablation Gynaecology Pelvis Women's Health Invasive Solutions Mammal Female Reproductive System

Is UTRS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 10.37
52 Week Low 4.682
Average Volume 172,635
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 7.70
10-Day Moving Average 6.21
Average True Range 0.82
ADX 46.27
+DI 5.45
-DI 28.06
Chandelier Exit (Long, 3 ATRs) 7.68
Chandelier Exit (Short, 3 ATRs) 7.14
Upper Bollinger Bands 10.94
Lower Bollinger Band 4.46
Percent B (%b) 0.17
BandWidth 84.04
MACD Line -1.10
MACD Signal Line -0.89
MACD Histogram -0.2126
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.23
Resistance 3 (R3) 6.25 6.06 6.12
Resistance 2 (R2) 6.06 5.90 6.05 6.09
Resistance 1 (R1) 5.83 5.80 5.73 5.80 6.05
Pivot Point 5.64 5.64 5.59 5.63 5.64
Support 1 (S1) 5.40 5.48 5.31 5.38 5.13
Support 2 (S2) 5.21 5.38 5.20 5.09
Support 3 (S3) 4.98 5.21 5.06
Support 4 (S4) 4.95